Category Archives: Cell Therapy

Coronary heart disease and heart failure continue to be significant burdens to healthcare systems in the Western world. In the United States alone, there are 7.1 million survivors of myocardial infarction (MI) and 4.9 million people living with congestive heart failure (CHF).1 Despite recent advances in medical and device therapy for heart failure, the incidence, hospitalization, and mortality rates continue to rise. After receiving a diagnosis of CHF, 1 in 5 patients will be dead within 12 months.1 Therefore, any new treatment modality that benefits heart failure patients has the potential to result in a dramatic improvement in health outcomes and substantial cost savings for the community. The possibility of using stem cellbased therapies for people suffering an acute MI or living with CHF has captured the imagination of both the medical and popular communities. Since early reports in animal models >10 years ago,2,3 the stem cell field has made enormous advances in moving toward clinically applicable treatment options, and we now stand at the dawn of a new therapeutic era. An abundance of preclinical data demonstrate safety, feasibility, and efficacy, justifying the current entry into clinical trials of stem cell therapy in humans.48 This position, however, is extremely controversial, … Continue reading →

JOHN PELOZA, M.D.FIRST IN DALLAS TO LAUNCHREVOLUTIONARY STEM CELL THERAPY TO PROMOTE NATURAL HEALING FOR BACK PAIN A ground-breaking new treatment utilizing mesenchymal stem cells to treat patients with neck and back pain caused from degenerative disc disease, is being used by John Peloza, M.D. in Dallas. Mesenchymal stem cells are harvested from the patients hip bone, processed and then injected into the painful tissue during the same procedure. These particular cells have regenerative properties, helping to promote natural healing within the damaged disc or joint. There is no surgical exposure, damage to normal tissues or loss of motion in the spine. A spine surgeon & clinical researcher, Dr. Pelozawas the first in Dallas to utilize the treatment, and he is seeing great promise with pain relief for patients with degenerative disc disease. A pioneer in modern spine treatments, Dr. Peloza has been using mesenchymal stem cell therapy for years to promote bone growth in patients undergoing minimally invasive spine stabilization. This new technique has the potential to heal damaged or degenerative discs and joints with a biologic solution rather than major surgery. Stem cell therapy can be performed safely in an ambulatory surgery center under conscious sedation in most … Continue reading →

A Traumatic Brain Injury (TBI) occurs when a bump, blow, or jolt to the head causes injury to the brain. Falls, sports injuries, motor vehicle accidents, and violence are common causes of TBI. We are seeking individuals who have had Traumatic Brain Injury (TBI) to participate in current and future research studies for the treatment of TBI. We are currently seeking participants in a clinical trial of modified stem cell therapy for TBI called STEMTRA (STEM cell therapy for TRAumatic brain injury). Interested participants will complete a questionnaire for a TBI research participant recruitment registry. The information in the registry will be used to identify potential participants for STEMTRA and future clinical research studies. Stem cells are cells that have the potential to develop into different types of cells within the body. Th STEMTRA Study is investigating whether adult bone-marrow-derived stem cells improve function after TBI. A clinical trial is a research study designed to assess the safety or efficacy of a treatment or intervention. A participant recruitment registry is a listing of people who are interested in participating in research studies. Read more: Stem Cell Therapy for TBI | Study Eligibility ... … Continue reading →

Our integrative staff has been using regenerative therapy for almost 2 decades. Using regenerative injection treatments such as Stem Cells, Platelet Rich Plasma (PRP), Prolotherapy and Prolozone Injections we are able to fix the root cause of many orthopedic problems. Whether its to repair damage to cartilage such as in osteoarthitis of the knee, hip or shoulder or tightening or healing damages muscles and tendons such as rotator cuff tear and chronic spinal pain we are on the forefront of the most current methods in non surgical orthopedic regenerative therapy. Conventional medical treatment for neurological degenerative diseases makes no attempt to regenerate the damaged cells of diseased organs and tissues. Cell therapy, on the other hand, by stimulating regeneration, has the potential to restore function to injured, diseased, and debilitated neuronal. Using functional neurology, stem cell specific nutrition and specific neuronal stem cells Advanced Rejuvenation is finding great success with our brain based programs. Use your own stem cells to repair damage from lung disease.Since the lungs are one of our most vonerable organs when our regenerative capacity declines many will suffer COPD and other lung diseases as they age. Stem cells therapy can have a strong regenerative affected in … Continue reading →

Conference Series LLCinvites all the participants from all over the world to attend '8th World Congress on Cell & Stem Cell Research during March 20-22, 2017 in Orlando, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Stem cellsare cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans there are several types of stem cells, each with variable levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age. Objective Stem Cell Research-2017 has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Stem Cell Research 2017 will have an anticipated participation of 120+ delegates across the world to discuss the conference goal. Success Story: Cell Science Conference Series The success of the Cell Science conference series has given us the prospect to bring the gathering inOrlando,USA. Since its commencement in 2011 Cell Science series has witnessed … Continue reading →

Stem cellsare extracted from the placenta, which is generally discarded after childbirth, have shown promise as a treatment for many lifestyle diseases.It is surprising to learn that the placenta stem cells have been confirmed by medical researchers to remove freeradicals, strengthen the bodys guard and accelerate its ability to recover and boost our system. Featured in The New Paper Singapore. Used as a fundamental form of cellular therapy, Placenta has been known to contain rich growth factors, antibodies, minerals, vitamins and other nourishing nutrients with the ability to assist cell rejuvenation and renewal. Placenta has often being prescribed as remedy to help mothers to swiftly recover their strength and vitality after giving birth. In other cultures, such as the Italians use Placenta to boost lactation while Indians have been documented to use Placenta for wound healing. US President Barack Obama on the future of Miracle Stem Cell Therapy Recently, treatments involving Placenta Stem Cell have begun gaining popularity in the West because of its various growth abilities, the people who use this exclusive treatment include injured football stars, international athletes, who undergo Placenta Therapy have reported to achieve quicker recovery than their doctors predicted. In the earlier days of the … Continue reading →

But that means about 2.5 million Americans live with heart failure that blocks blood vessels and reduces blood supply to the body. A new study provides an early indication that cell therapy using cells from bone marrow could one day help treat heart failure. Researchers gave 60 patients with heart failure an injection of the therapy in the heart and compared their rates of death and heart problems to those of 66 similar patients who received a placebo injection of saltwater in the heart. The researchers found that, during the year following the treatment, the patients who received the cell therapy had a 37% lower rate of death and hospitalization for heart failure-related problems, such as fluid buildup in the body or shortness of breath, compared with the placebo group. In the cell therapy group, 3.4% of the patients died and 51.7% were hospitalized for heart problems, whereas 13.7% of the placebo group died and 82.4% were hospitalized. In the year after the injection, 20.3% of the patients in the cell therapy group experienced an adverse event such as infection or stroke, compared with 41.8% of the placebo group. "It was surprising that the (placebo) patients did significantly worse," Patel … Continue reading →

What if doctors could grow a new working inner ear from a persons own skin cells? Or repair the damaged inner ear from within? Solving this profound mystery is the driving force behind stem cell research and the promise of tissue engineering in otolaryngology. While hearing aids and cochlear implants can provide good recovery of hearing function, the development of a biological method to repair the damaged cochlea has the potential to restore normal hearing without any type of prosthesis. One approach to restore hearing might be to surgically place stem cells within the cochlea in such a way that they would fuse with the remaining cochlear structures and develop and function as hair cells. Scientists believe this is a viable approach because, unlike most organs that are destroyed by disease, the inner ear remains structurally intactonly the hair cells are lost. By mimicking the steps involved in the formation of embryonic mouse ears, Stanford scientists have produced stem cells in the laboratory that look and act very much like hair cells, the sensory cells that normally reside in the inner ear. If they can generate hair cells in the millions, it could lead to significant scientific and clinical advances … Continue reading →

Adult (Somatic) stem cells are unspecialized cells that are found in different parts of the body and, depending on the source tissue, have different properties. Adult stem cells are capable of self-renewal and give rise to daughter cells that are specialized to form the cell types found in the original body part. Adult stem cells are multipotent, meaning that they appear to be limited in the cell types that they can produce based on current evidence. However, recent scientific studies suggest that adult stem cells may have more plasticity than originally thought. Stem cell plasticity is the ability of a stem cell from one tissue to generate the specialized cell type(s) of another tissue. For example, bone marrow stromal cells are known to give rise to bone cells, cartilage cells, fat cells and other types of connective tissue (which is expected), but they may also differentiate into cardiac muscle cells and skeletal muscle cells (this was not initially thought possible). Hematopoietic stem cells that give rise to all blood and immune cells are today the most understood of the adult stem cells. Hematopoietic stem cells from bone marrow have been providing lifesaving cures for leukemia and other blood disorders for … Continue reading →

January 20, 2016 04:30 ET | Source: Transparency Market Research Albany, NY, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Cell separation technologies make it possible to isolate target cells from a mixture of various cells. The growing prevalence of chronic diseases has fuelled the demand for cell therapies to understand the cause of the diseases. This has augmented the growth of the global cell separation technologies market. The overall market was worth US$1.7 bn in 2012. Rapidly growing patient pool and increase in research and development activities by biotechnology companies are expected to expand the market at a CAGR of 9.7% during the period between 2013 and 2019. The global cell separation technologies market is anticipated to reach a valuation of US$3.3 bn by 2019. Initiatives adopted by governments worldwide aimed at improving the biotechnology sector boost the growth of the global cell separation technologies market. The growing prevalence of diseases such as cancer has escalated the demand for cell therapy. However, the market is expected to be restrained by disputes related to patent rights over magnetic activated cell sorting (MACS) technique. The overall market has huge opportunity to grow with technological advancements. Browse Research Report on Cell Separation Technologies Market: … Continue reading →